The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
Khan S, Fawaz S, Simpson R, Robertson C, Kelly P, Mohdnazri S, Tang K, Cook CM, Gallagher S, O'Kane P, Spratt J, Brilakis ES, Karamasis GV, Al-Lamee R, Keeble TR, Davies JR.
Khan S, et al. Among authors: gallagher s.
Front Cardiovasc Med. 2023 May 3;10:1172763. doi: 10.3389/fcvm.2023.1172763. eCollection 2023.
Front Cardiovasc Med. 2023.
PMID: 37206100
Free PMC article.